Detalhe da pesquisa
1.
Extended-release naltrexone/bupropion is safe and effective among subjects with type 2 diabetes already taking incretin agents: a post-hoc analysis of the LIGHT trial.
Int J Obes (Lond)
; 45(8): 1687-1695, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083744
2.
Extended-release naltrexone/bupropion and liver health: Pooled, post hoc analysis from four randomized controlled trials.
Diabetes Obes Metab
; 23(3): 861-865, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33275326
3.
Efficacy of brodalumab in moderate-to-severe plaque psoriasis after failure of previous biologic therapy: A phase 4, multicenter, open-label study.
J Am Acad Dermatol
; 90(6): 1254-1256, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290619
4.
Brodalumab success in patients with moderate-to-severe psoriasis who failed previous interleukin-17A inhibitors.
J Am Acad Dermatol
; 84(4): 1169-1171, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33221464
5.
Improving implementation of best practices in obesity management: Physician experiences in obesity care.
Clin Obes
; 14(1): e12624, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846529
6.
Ribavirin aerosol in hospitalized adults with respiratory distress and COVID-19: An open-label trial.
Clin Transl Sci
; 16(1): 165-174, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36326174
7.
A randomized, placebo-controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin.
Clin Transl Sci
; 15(9): 2159-2171, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35677972
8.
The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy.
EClinicalMedicine
; 49: 101436, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35747175
9.
The i-ACT™ in Obesity educational intervention: a pilot study on improving Canadian family physician care in obesity medicine.
BMC Prim Care
; 23(1): 101, 2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35501830
10.
Psychiatric Safety and Weight Loss Efficacy of Naltrexone/bupropion as Add-on to Antidepressant Therapy in Patients with Obesity or Overweight.
J Affect Disord
; 289: 167-176, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989969
11.
Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series.
Infect Dis Ther
; 10(4): 2791-2804, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302258
12.
Clinical Performance of Samfilcon A Contact Lenses in Intensive Digital Device Users: A Multicenter, Prospective Clinical Study.
Ophthalmol Ther
; 10(4): 957-972, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34487319
13.
Regional variability in Canadian routine care of type 2 diabetes, hypercholesterolemia, and hypertension: Results from the The Cardio-Vascular and metabolic treatments in Canada: Assessment of REal-life therapeutic value (CV-CARE) registry.
J Cardiol
; 76(4): 385-394, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32473770
14.
Real-world effectiveness of treatments for type 2 diabetes, hypercholesterolemia, and hypertension in Canadian routine care - Results from the CardioVascular and metabolic treatment in Canada: Assessment of REal-life therapeutic value (CV-CARE) registry, 12-months results.
Diabetes Res Clin Pract
; 170: 108416, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32891688
15.
Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review.
JAAD Int
; 8: 60-63, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35721301
16.
Correction to: Clinical Performance of Samfilcon A Contact Lenses in Intensive Digital Device Users: A Multicenter, Prospective Clinical Study.
Ophthalmol Ther
; 10(4): 973-974, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34677791
17.
Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach.
J Affect Disord
; 156: 1-7, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24314926